Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Robert Naclerio to Histamine Release

This is a "connection" page, showing publications Robert Naclerio has written about Histamine Release.

 
Connection Strength
 
 
 
2.188
 
  1. Naclerio R. Clinical manifestations of the release of histamine and other inflammatory mediators. J Allergy Clin Immunol. 1999 Mar; 103(3 Pt 2):S382-5.
    View in: PubMed
    Score: 0.205
  2. Baroody FM, Ford S, Proud D, Kagey-Sobotka A, Lichtenstein L, Naclerio RM. Relationship between histamine and physiological changes during the early response to nasal antigen provocation. J Appl Physiol (1985). 1999 Feb; 86(2):659-68.
    View in: PubMed
    Score: 0.204
  3. Wagenmann M, Baroody FM, Cheng CC, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Bilateral increases in histamine after unilateral nasal allergen challenge. Am J Respir Crit Care Med. 1997 Feb; 155(2):426-31.
    View in: PubMed
    Score: 0.178
  4. Naclerio RM, Hubbard W, Lichtenstein LM, Kagey-Sobotka A, Proud D. Origin of late phase histamine release. J Allergy Clin Immunol. 1996 Oct; 98(4):721-3.
    View in: PubMed
    Score: 0.174
  5. Baroody FM, Ford S, Lichtenstein LM, Kagey-Sobotka A, Naclerio RM. Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine. Am J Respir Crit Care Med. 1994 Jun; 149(6):1457-65.
    View in: PubMed
    Score: 0.148
  6. Naclerio RM. Effects of antihistamines on inflammatory mediators. Ann Allergy. 1993 Sep; 71(3):292-5.
    View in: PubMed
    Score: 0.140
  7. Cruz AA, Togias AG, Lichtenstein LM, Kagey-Sobotka A, Proud D, Naclerio RM. Steroid-induced reduction of histamine release does not alter the clinical nasal response to cold, dry air. Am Rev Respir Dis. 1991 Apr; 143(4 Pt 1):761-5.
    View in: PubMed
    Score: 0.119
  8. Naclerio RM, Kagey-Sobotka A, Lichtenstein LM, Freidhoff L, Proud D. Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human. Am Rev Respir Dis. 1990 Jul; 142(1):167-71.
    View in: PubMed
    Score: 0.113
  9. Togias AG, Proud D, Lichtenstein LM, Adams GK, Norman PS, Kagey-Sobotka A, Naclerio RM. The osmolality of nasal secretions increases when inflammatory mediators are released in response to inhalation of cold, dry air. Am Rev Respir Dis. 1988 Mar; 137(3):625-9.
    View in: PubMed
    Score: 0.096
  10. Baroody FM, Foster KA, Markaryan A, deTineo M, Naclerio RM. Nasal ocular reflexes and eye symptoms in patients with allergic rhinitis. Ann Allergy Asthma Immunol. 2008 Mar; 100(3):194-9.
    View in: PubMed
    Score: 0.096
  11. Naclerio RM, Bartenfelder D, Proud D, Togias AG, Meyers DA, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Theophylline reduces histamine release during pollen-induced rhinitis. J Allergy Clin Immunol. 1986 Nov; 78(5 Pt 1):874-6.
    View in: PubMed
    Score: 0.087
  12. Naclerio RM, Proud D, Togias AG, Adkinson NF, Meyers DA, Kagey-Sobotka A, Plaut M, Norman PS, Lichtenstein LM. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med. 1985 Jul 11; 313(2):65-70.
    View in: PubMed
    Score: 0.080
  13. Allocco FT, Votypka V, deTineo M, Naclerio RM, Baroody FM. Effects of fexofenadine on the early response to nasal allergen challenge. Ann Allergy Asthma Immunol. 2002 Dec; 89(6):578-84.
    View in: PubMed
    Score: 0.067
  14. Desrosiers M, Proud D, Naclerio RM. Lack of effect of hot, humid air on response to nasal challenge with histamine. Ann Otol Rhinol Laryngol. 1996 Feb; 105(2):146-54.
    View in: PubMed
    Score: 0.041
  15. Naclerio RM, Baroody FM, Kagey-Sobotka A, Lichtenstein LM. Basophils and eosinophils in allergic rhinitis. J Allergy Clin Immunol. 1994 Dec; 94(6 Pt 2):1303-9.
    View in: PubMed
    Score: 0.038
  16. Wagenmann M, Baroody FM, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. The effect of terfenadine on unilateral nasal challenge with allergen. J Allergy Clin Immunol. 1994 Mar; 93(3):594-605.
    View in: PubMed
    Score: 0.036
  17. Majchel AM, Baroody F, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Effect of oxymetazoline on the early response to nasal challenge with antigen. J Allergy Clin Immunol. 1993 Nov; 92(5):767-70.
    View in: PubMed
    Score: 0.035
  18. Iliopoulos O, Baroody FM, Naclerio RM, Bochner BS, Kagey-Sobotka A, Lichtenstein LM. Histamine-containing cells obtained from the nose hours after antigen challenge have functional and phenotypic characteristics of basophils. J Immunol. 1992 Apr 01; 148(7):2223-8.
    View in: PubMed
    Score: 0.032
  19. Majchel AM, Proud D, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Ketotifen reduces sneezing but not histamine release following nasal challenge with antigen. Clin Exp Allergy. 1990 Nov; 20(6):701-5.
    View in: PubMed
    Score: 0.029
  20. Wachs M, Proud D, Lichtenstein LM, Kagey-Sobotka A, Norman PS, Naclerio RM. Observations on the pathogenesis of nasal priming. J Allergy Clin Immunol. 1989 Oct; 84(4 Pt 1):492-501.
    View in: PubMed
    Score: 0.027
  21. Iliopoulos O, Proud D, Norman PS, Lichtenstein LM, Kagey-Sobotka A, Naclerio RM. Nasal challenge with cold, dry air induces a late-phase reaction. Am Rev Respir Dis. 1988 Aug; 138(2):400-5.
    View in: PubMed
    Score: 0.025
  22. Silber G, Proud D, Warner J, Naclerio R, Kagey-Sobotka A, Lichtenstein L, Eggleston P. In vivo release of inflammatory mediators by hyperosmolar solutions. Am Rev Respir Dis. 1988 Mar; 137(3):606-12.
    View in: PubMed
    Score: 0.024
  23. Naclerio RM, Proud D, Lichtenstein LM, Kagey-Sobotka A, Hendley JO, Sorrentino J, Gwaltney JM. Kinins are generated during experimental rhinovirus colds. J Infect Dis. 1988 Jan; 157(1):133-42.
    View in: PubMed
    Score: 0.024
  24. Pipkorn U, Proud D, Lichtenstein LM, Schleimer RP, Peters SP, Adkinson NF, Kagey-Sobotka A, Norman PS, Naclerio RM. Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. J Clin Invest. 1987 Oct; 80(4):957-61.
    View in: PubMed
    Score: 0.023
  25. MacDonald SM, Lichtenstein LM, Proud D, Plaut M, Naclerio RM, MacGlashan DW, Kagey-Sobotka A. Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE. J Immunol. 1987 Jul 15; 139(2):506-12.
    View in: PubMed
    Score: 0.023
  26. Pipkorn U, Proud D, Lichtenstein LM, Kagey-Sobotka A, Norman PS, Naclerio RM. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med. 1987 Jun 11; 316(24):1506-10.
    View in: PubMed
    Score: 0.023
  27. Togias AG, Naclerio RM, Warner J, Proud D, Kagey-Sobotka A, Nimmagadda I, Norman PS, Lichtenstein LM. Demonstration of inhibition of mediator release from human mast cells by azatadine base. In vivo and in vitro evaluation. JAMA. 1986 Jan 10; 255(2):225-9.
    View in: PubMed
    Score: 0.021
  28. Naclerio RM, Bartenfelder D, Proud D, Togias AG, Meyers DA, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Theophylline reduces the response to nasal challenge with antigen. Am J Med. 1985 Dec 20; 79(6A):43-7.
    View in: PubMed
    Score: 0.021
  29. Schleimer RP, MacGlashan DW, Peters SP, Naclerio R, Proud D, Adkinson NF, Lichtenstein LM. Inflammatory mediators and mechanisms of release from purified human basophils and mast cells. J Allergy Clin Immunol. 1984 Oct; 74(4 Pt 1):473-81.
    View in: PubMed
    Score: 0.019
  30. Hedlin G, Silber G, Schieken L, Naclerio R, Proud D, Eggleston P, Adkinson NF. Attenuation of allergen sensitivity early in the course of ragweed immunotherapy. J Allergy Clin Immunol. 1989 Sep; 84(3):390-9.
    View in: PubMed
    Score: 0.007
  31. Freeland HS, Pipkorn U, Schleimer RP, Bascom R, Lichtenstein LM, Naclerio RM, Peters SP. Leukotriene B4 as a mediator of early and late reactions to antigen in humans: the effect of systemic glucocorticoid treatment in vivo. J Allergy Clin Immunol. 1989 Mar; 83(3):634-42.
    View in: PubMed
    Score: 0.006
  32. Bascom R, Wachs M, Naclerio RM, Pipkorn U, Galli SJ, Lichtenstein LM. Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol. 1988 Mar; 81(3):580-9.
    View in: PubMed
    Score: 0.006
  33. Baumgarten CR, Naclerio RM, Togias AG, Lichtenstein LM, Norman PS, Proud D. Kininogens in nasal secretions after allergen challenge. Adv Exp Med Biol. 1986; 198 Pt B:189-92.
    View in: PubMed
    Score: 0.005
  34. Creticos PS, Adkinson NF, Kagey-Sobotka A, Proud D, Meier HL, Naclerio RM, Lichtenstein LM, Norman PS. Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy. J Clin Invest. 1985 Dec; 76(6):2247-53.
    View in: PubMed
    Score: 0.005
  35. Togias AG, Naclerio RM, Proud D, Fish JE, Adkinson NF, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. J Clin Invest. 1985 Oct; 76(4):1375-81.
    View in: PubMed
    Score: 0.005
  36. Schleimer RP, Fox CC, Naclerio RM, Plaut M, Creticos PS, Togias AG, Warner JA, Kagey-Sobotka A, Lichtenstein LM. Role of human basophils and mast cells in the pathogenesis of allergic diseases. J Allergy Clin Immunol. 1985 Aug; 76(2 Pt 2):369-74.
    View in: PubMed
    Score: 0.005
  37. Norman PS, Naclerio RM, Creticos PS, Togias A, Lichtenstein LM. Mediator release after allergic and physical nasal challenges. Int Arch Allergy Appl Immunol. 1985; 77(1-2):57-63.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.